A citation-based method for searching scientific literature

Takeshi Fuchigami, Mamoru Haratake, Yasuhiro Magata, Terushi Haradahira, Morio Nakayama. Bioorg Med Chem 2011
Times Cited: 5







List of co-cited articles
101 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
Mario Mezler, Wilfried Hornberger, Reinhold Mueller, Martin Schmidt, Willi Amberg, Wilfried Braje, Michael Ochse, Hans Schoemaker, Berthold Behl. Mol Pharmacol 2008
46
80

Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain.
Beatriz Cubelos, Cecilio Giménez, Francisco Zafra. Cereb Cortex 2005
221
80

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne-Bouhtou, Annick Coste, Christophe Lanneau, Christophe Desvignes, Martine Poncelet, Michel Heaulme, Vincent Santucci, Michel Decobert,[...]. Neuropsychopharmacology 2005
178
80

The synthesis and preclinical evaluation in rhesus monkey of [¹⁸F]MK-6577 and [¹¹C]CMPyPB glycine transporter 1 positron emission tomography radiotracers.
Terence G Hamill, Waisi Eng, Andrew Jennings, Richard Lewis, Steven Thomas, Suzanne Wood, Leslie Street, David Wisnoski, Scott Wolkenberg, Craig Lindsley,[...]. Synapse 2011
31
60

Translational characterization of [11C]GSK931145, a PET ligand for the glycine transporter type 1.
Roger N Gunn, Venkatesha Murthy, Ana M Catafau, Graham Searle, Santiago Bullich, Mark Slifstein, Daniele Ouellet, Stefano Zamuner, Raul Herance, Cristian Salinas,[...]. Synapse 2011
36
60

Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition.
Jesús Gomeza, Swen Hülsmann, Koji Ohno, Volker Eulenburg, Katalin Szöke, Diethelm Richter, Heinrich Betz. Neuron 2003
235
60

Glycine transporters are differentially expressed among CNS cells.
F Zafra, C Aragón, L Olivares, N C Danbolt, C Giménez, J Storm-Mathisen. J Neurosci 1995
420
60

Glycine transporters: essential regulators of neurotransmission.
Volker Eulenburg, Wencke Armsen, Heinrich Betz, Jesús Gomeza. Trends Biochem Sci 2005
242
60

Identification and evaluation of [11C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography.
J Passchier, G Gentile, R Porter, H Herdon, C Salinas, S Jakobsen, H Audrain, M Laruelle, R N Gunn. Synapse 2010
27
60


Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.
U Heresco-Levy, D C Javitt, M Ermilov, C Mordel, A Horowitz, D Kelly. Br J Psychiatry 1996
197
60

A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies.
Zhizhen Zeng, Julie A O'Brien, Wei Lemaire, Stacey S O'Malley, Patricia J Miller, Zhijian Zhao, Michael A Wallace, Conrad Raab, Craig W Lindsley, Cyrille Sur,[...]. Nucl Med Biol 2008
23
60

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.
U Heresco-Levy, D C Javitt, M Ermilov, C Mordel, G Silipo, M Lichtenstein. Arch Gen Psychiatry 1999
352
60

The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter.
John A Lowe, Xinjun Hou, Christopher Schmidt, F David Tingley, Stan McHardy, Monica Kalman, Shari Deninno, Mark Sanner, Karen Ward, Lorraine Lebel,[...]. Bioorg Med Chem Lett 2009
27
60

A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia.
Hsien-Yuan Lane, Ching-Hua Lin, Yu-Jhen Huang, Chun-Hui Liao, Yue-Cune Chang, Guochuan E Tsai. Int J Neuropsychopharmacol 2010
125
60


High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.
Uriel Heresco-Levy, Marina Ermilov, Pesah Lichtenberg, Gali Bar, Daniel C Javitt. Biol Psychiatry 2004
171
60

Amelioration of negative symptoms in schizophrenia by glycine.
D C Javitt, I Zylberman, S R Zukin, U Heresco-Levy, J P Lindenmayer. Am J Psychiatry 1994
286
60

ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter.
B N Atkinson, S C Bell, M De Vivo, L R Kowalski, S M Lechner, V I Ognyanov, C S Tham, C Tsai, J Jia, D Ashton,[...]. Mol Pharmacol 2001
146
60


Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS.
F Zafra, J Gomeza, L Olivares, C Aragón, C Giménez. Eur J Neurosci 1995
229
60


Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.
Pierre J Mallorga, Jacinta B Williams, Marlene Jacobson, Rosemary Marques, Ashok Chaudhary, P Jeffrey Conn, Douglas J Pettibone, Cyrille Sur. Neuropharmacology 2003
53
60



Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: evidence from genetically modified mouse models and pharmacological inhibition.
Hanns Möhler, Detlev Boison, Philipp Singer, Joram Feldon, Meike Pauly-Evers, Benjamin K Yee. Biochem Pharmacol 2011
35
40


Recent progress in the discovery of non-sarcosine based GlyT1 inhibitors.
Scott E Wolkenberg, Cyrille Sur. Curr Top Med Chem 2010
29
40

Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
Toshihiro Dohi, Katsuya Morita, Tomoya Kitayama, Naoyo Motoyama, Norimitsu Morioka. Pharmacol Ther 2009
77
40

Neurotransmitter transporters: molecular function of important drug targets.
Ulrik Gether, Peter H Andersen, Orla M Larsson, Arne Schousboe. Trends Pharmacol Sci 2006
224
40

Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography.
Edilio Borroni, Yun Zhou, Susanne Ostrowitzki, Daniela Alberati, Anil Kumar, Dominik Hainzl, Thomas Hartung, John Hilton, Robert F Dannals, Dean F Wong. Neuroimage 2013
14
40

Design, synthesis, and SAR of N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1.
Christopher L Cioffi, Mark A Wolf, Peter R Guzzo, Kashinath Sadalapure, Visweswaran Parthasarathy, Dattatraya Dethe, Jun-Ho Maeng, Edmund Carulli, David T J Loong, Xiao Fang,[...]. Bioorg Med Chem Lett 2013
4
50



Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans.
Dean F Wong, Susanne Ostrowitzki, Yun Zhou, Vanessa Raymont, Carsten Hofmann, Edilio Borroni, Anil Kumar, Nikhat Parkar, James R Brašić, John Hilton,[...]. Neuroimage 2013
19
40

Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors.
Joanne L Thomson, Wesley P Blackaby, Andrew S R Jennings, Simon C Goodacre, Andrew Pike, Steve Thomas, Terry A Brown, Alison Smith, Gopalan Pillai, Leslie J Street,[...]. Bioorg Med Chem Lett 2009
10
40

Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1.
Jeffrey G Varnes, Janet M Forst, Tiffany N Hoerter, Christopher R Holmquist, Deidre E Wilkins, Gaochao Tian, Gerald Jonak, Xia Wang, William M Potts, Michael W Wood,[...]. Bioorg Med Chem Lett 2010
4
50

Recent advances in the phencyclidine model of schizophrenia.
D C Javitt, S R Zukin. Am J Psychiatry 1991
40


Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
Enrique Núñez, Rodrigo Martínez-Maza, Arjan Geerlings, Carmen Aragón, Beatriz López-Corcuera. Neuropharmacology 2005
7
40

LeuT conformational sampling utilizing accelerated molecular dynamics and principal component analysis.
James R Thomas, Patrick C Gedeon, Barry J Grant, Jeffry D Madura. Biophys J 2012
25
40

Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
Hsien-Yuan Lane, Yue-Cune Chang, Yi-Ching Liu, Chih-Chiang Chiu, Guochuan E Tsai. Arch Gen Psychiatry 2005
208
40

Involvement of accumbal glycine receptors in the regulation of voluntary ethanol intake in the rat.
Anna Molander, Elin Löf, Rosita Stomberg, Mia Ericson, Bo Söderpalm. Alcohol Clin Exp Res 2005
73
40


Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.
Deepak Cyril D'Souza, Nagendra Singh, Jacqueline Elander, Michelle Carbuto, Brian Pittman, Joanna Udo de Haes, Magnus Sjogren, Pierre Peeters, Mohini Ranganathan, Jacques Schipper. Neuropsychopharmacology 2012
46
40

Memories of NMDA receptors and LTP.
G L Collingridge, T V Bliss. Trends Neurosci 1995
313
40

Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
Katsuya Morita, Naoyo Motoyama, Tomoya Kitayama, Norimitsu Morioka, Koki Kifune, Toshihiro Dohi. J Pharmacol Exp Ther 2008
96
40

Cloning and expression of a glycine transporter from mouse brain.
Q R Liu, H Nelson, S Mandiyan, B López-Corcuera, N Nelson. FEBS Lett 1992
155
40

Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia.
Emmanuel Pinard, Alexander Alanine, Daniela Alberati, Markus Bender, Edilio Borroni, Patrick Bourdeaux, Virginie Brom, Serge Burner, Holger Fischer, Dominik Hainzl,[...]. J Med Chem 2010
94
40



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.